Public Hearing on:
FDA Regulation of Combination Products

Monday, November 25, 2002

AGENDA

8:00 - 9:00		Doors Open
9:00 - 9:15		Opening Remarks Mark Barnett Murray Lumpkin, M.D.
9:15 - 9:30		American Academy of Orthopaedic Surgeons Barbara D. Boyan, Ph.D. Powerpoint Presentation Text Version
9:30 - 9:45		Genetronics, Inc. Paul Goldfarb, M.D. Text Version
9:45 - 10:05		Angiogene, Inc. Guy Chamberland, Ph.D. Powerpoint Presentation Text Version
10:05 - 10:20		Wyeth Pharmaceuticals, Inc. F. Owen Fields, Ph.D. Powerpoint Presentation Text Version
10:20 - 10:30		Nephros Therapeutics, Inc. Zorina Pitkin, Ph.D., RAC Powerpoint Presentation Text Version
10:30 – 10:45		Carnegie Mellon University Mark Hamblin Powerpoint Presentation Text Version
10:45 – 11:00		BREAK

11:00 – 11:20		National Electrical Manufacturers Association Terry Sweeney Powerpoint Presentation Text Version
11:20 – 11:30		Medical Imaging Contrast Agent Association Alan Kirschenbaum, Esq. Powerpoint Presentation Text Version
11:30 – 11:45		Hogan & Hartson, LLP David Fox Powerpoint Presentation Text Version
11:45 – 12:05		AdvaMed Janet Trunzo or alternate Patricia Shrader PDF [183KB] HTML Carolyn Jones PDF [217KB] HTML Daniel Troy ltr. PDF [302KB] HTML
12:05 – 12:20		Aventis Behring Michael Gross, Ph.D. Powerpoint Presentation Testimony
12:20 – 1:20		Open Microphone Session (Members of the audience may make further brief comments as time permits)
1:20 – 1:30		Closing Remarks and Adjournment

horizonal rule